The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management
Open accessAbstract
Patients with inflammatory bowel diseases (IBDs), such as ulcerative colitis and Crohn’s disease, have an increased risk of developing colorectal cancer (CRC). Although advancements in endoscopic imaging techniques, integrated surveillance programs, and improved medical therapies have contributed to a decreased incidence of CRC in patients with IBD, the rate of CRC remains higher in patients with IBD than in individuals without chronic colitis. Patients with IBD-related CRCs exhibit a poorer prognosis than those with sporadic CRCs, owing to their aggressive histological characteristics and lower curative resection rate. In this review, we present an updated overview of the epidemiology, etiology, risk factors, surveillance strategies, treatment recommendations, and prognosis of IBD-related CRCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Colonoscopy is the optimal strategy for the prevention of CRC in patients with IBD[44].”
From Risk factors, prevention and screening of colorectal cancer: A rising problem (2025) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959 · cited 2×
“2%, with cumulative risks of 2%, 8%, and 18% at 10, 20, and 30 years, respectively [13].”
BackgroundLamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910 · cited 1×
“Recently, several new endoscopic techniques have emerged to identify dysplastic or cancerous lesions [8,9].”
BackgroundMaaser, C., Sturm, A., Vavricka, S. R., Kucharzik, T., Fiorino, G., Annese, V., Calabrese, E., Baumgart, D. C., Bettenworth, D., Borralho Nunes, P., et al. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjy113 · Cited by 1,823 · cited 1×
“BSG 2019 [46] HD-WLE rather than SD-WLE SD or HD-WLE with DCE”
MethodUlcerative Colitis and Colorectal Cancer: A Population-Based Study
Ekbom, A., Helmick, C., Zack, M., & Adami, H.-O. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231802 · Cited by 1,777 · cited 2×
“Patients with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), have an increased risk of developing colorectal cancer (CRC) [1,2].”
BackgroundACG Clinical Guideline: Ulcerative Colitis in Adults
Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Sauer, B. G., & Long, M. D. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000152 · Cited by 1,577 · cited 5×
“ACG 2019 [8] SD colonoscopy with DCE HD-WLE with NBI or DCE”
BackgroundMethodInfluentialDignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
Itzkowitz, S. H., & Yio, X. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00079.2004 · Cited by 1,274 · cited 1×
“Chronic inflammation causes oxidative stress-induced injuries [22].”
Harbord, M., Eliakim, R., Bettenworth, D., Karmiris, K., Katsanos, K., Kopylov, U., Kucharzik, T., Molnár, T., Raine, T., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx009 · Cited by 1,180
Intestinal Inflammation and Cancer
Ullman, T. A., & Itzkowitz, S. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.057 · Cited by 1,119 · cited 1×
“However, unlike sporadic CRC, IBD-CRC does not follow the conventional adenoma–carcinoma sequence; instead, it can progress from low- to high-grade dysplasia (HGD) and ultimately to CRC [31].”
Background
Cited by
Inflammatory Bowel Disease and Colorectal Cancer
Fanizza, J., Bencardino, S., Allocca, M., Furfaro, F., Zilli, A., Parigi, T. L., Fiorino, G., Peyrin‐Biroulet, L., Danese, S., & D’Amico, F. (2024) · Cancers · doi:10.3390/cancers16172943 · Cited by 63
“The risk of IBD-CRC is significantly elevated (by as much as two to three times) in patients with a history of UC and CD of at least 8 years long-standing, referred to as ‘long-standing’ [3].”
BackgroundInfluentialRisk factors, prevention and screening of colorectal cancer: A rising problem
Tsukanov, V. V., Vasyutin, A. V., & Tonkikh, J. L. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i5.98629 · Cited by 42
Diet-microbiome interactions in cancer
Abdeen, S. K., Mastandrea, I., Stinchcombe, N., Puschhof, J., & Elinav, E. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.013 · Cited by 36
Baas, F. S., Brusselaers, N., Nagtegaal, I. D., Engstrand, L. G., & Boleij, A. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.008 · Cited by 36
Antioxidant Role of Probiotics in Inflammation-Induced Colorectal Cancer
Hamamah, S., Lobiuc, A., & Covașă, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169026 · Cited by 36
“Inflammation is a significant risk factor for CRC development as those with inflammatory bowel disease (IBD) experience up to a three-fold increased incidence of the condition [65].”
Background
Metadata
- Authors
- Sato, Y., Tsujinaka, S., Miura, T., Kitamura, Y., Suzuki, H., & Shibata, C.
- Affiliations
- Tohoku Medical and Pharmaceutical University Hospital (JP)
- Corresponding author
- Tsujinaka, Shingo
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2023-08-17
- Volume
- 15
- Issue
- 16
- Pages
- 4154
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC10452690
- OpenAlex
- W4385949386
- Semantic Scholar
- 9923dd56bd14e9fa0eaa73626ab070fd6890f050
- Cited by
- 111
- References
- 82
- Citations by year
- 2026: 36 · 2025: 45 · 2024: 25 · 2023: 5
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- inflammatory bowel disease, colorectal cancer, ulcerative colitis, Crohn's disease, cancer surveillance, endoscopic surveillance, risk factors, prognosis, curative resection, histological characteristics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management. https://app.cochat.ai/papers/10.3390/cancers15164154
- The paper
- Sato, Y., Tsujinaka, S., Miura, T., Kitamura, Y., Suzuki, H., & Shibata, C. (2023). Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management. Cancers. https://doi.org/10.3390/cancers15164154
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.